149 related articles for article (PubMed ID: 9805252)
1. Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing.
Nakagawa H; Kobayashi Y; Kikushima S; Shinohara M; Obara C; Zinbo Y; Chiyoda K; Miyata A; Tanno K; Baba T; Katagiri T
Jpn Circ J; 1998 Oct; 62(10):727-32. PubMed ID: 9805252
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
[TBL] [Abstract][Full Text] [Related]
3. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt.
Morillo CA; Leitch JW; Yee R; Klein GJ
J Am Coll Cardiol; 1993 Dec; 22(7):1843-8. PubMed ID: 8245337
[TBL] [Abstract][Full Text] [Related]
4. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
Cox MM; Perlman BA; Mayor MR; Silberstein TA; Levin E; Pringle L; Castellanos A; Myerburg RJ
J Am Coll Cardiol; 1995 Nov; 26(5):1293-8. PubMed ID: 7594046
[TBL] [Abstract][Full Text] [Related]
5. Tilt testing in neurocardiogenic syncope: isosorbide versus isoproterenol.
Hermosillo AG; Marquez MF; Jauregui-Renaud K; Falcon JC; Casanova JM; Guevara M; Cardenas M
Acta Cardiol; 2000 Dec; 55(6):351-5. PubMed ID: 11227835
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of head-up tilt test with intravenous beta-blocker administration in assessing the efficacy of therapy in patients with vasovagal syncope.
Gielerak G; Makowski K; Cholewa M
Ann Noninvasive Electrocardiol; 2005 Jan; 10(1):65-72. PubMed ID: 15649240
[TBL] [Abstract][Full Text] [Related]
7. Head-up tilt test with isoproterenol provocation in syncope of unknown origin.
Ryu MH; Cho JG; Bae Y; Rhew JY; Chung YJ; Youn S; Jeong MH; Park JC; Kang JC
Korean J Intern Med; 1996 Jun; 11(2):108-12. PubMed ID: 8854646
[TBL] [Abstract][Full Text] [Related]
8. Impedance cardiography: a role in vasovagal syncope diagnosis?
Parry SW; Norton M; Pairman J; Baptist M; Wilton K; Reeve P; Sutcliffe K; Newton JL
Age Ageing; 2009 Nov; 38(6):718-23. PubMed ID: 19749201
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous adenosine in vasovagal syncope.
Sinkovec M; Grad A; Rakovec P
Clin Auton Res; 2001 Jun; 11(3):155-61. PubMed ID: 11605820
[TBL] [Abstract][Full Text] [Related]
10. Enhanced plasma catecholamine and cAMP response during the head-up tilt test in patients with vasovagal syncope.
Mitro P; Rybárová E; Zemberová E; Tkác I
Wien Klin Wochenschr; 2005 May; 117(9-10):353-8. PubMed ID: 15989115
[TBL] [Abstract][Full Text] [Related]
11. Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis.
Forleo C; Guida P; Iacoviello M; Resta M; Monitillo F; Sorrentino S; Favale S
Int J Cardiol; 2013 Sep; 168(1):27-35. PubMed ID: 23041006
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope].
Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barsotti A
Cardiologia; 1998 Aug; 43(8):833-7. PubMed ID: 9808874
[TBL] [Abstract][Full Text] [Related]
13. The influence of a tilt training programme on the renin-angiotensin-aldosterone system activity in patients with vasovagal syncope.
Gajek J; Zyśko D; Krzemińska S; Mazurek W
Acta Cardiol; 2009 Aug; 64(4):505-9. PubMed ID: 19725444
[TBL] [Abstract][Full Text] [Related]
14. A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test.
Ventura R; Maas R; Zeidler D; Schoder V; Nienaber CA; Schuchert A; Meinertz T
Pacing Clin Electrophysiol; 2002 May; 25(5):816-21. PubMed ID: 12049374
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic changes during head-up tilt test and predictive value thereof in predicting the efficacy of metoprolol therapy in children with vasovagal syncope].
Zhang QY; DU JB; Zhen JL; Li WZ; Wang YL
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1260-2. PubMed ID: 17686261
[TBL] [Abstract][Full Text] [Related]
16. Nitrate-potentiated head-up tilt testing (HUT) has a low diagnostic yield in patients with likely vasovagal syncope.
Petix NR; Del Rosso A; Furlan R; Guarnaccia V; Zipoli A
Pacing Clin Electrophysiol; 2014 Feb; 37(2):164-72. PubMed ID: 23992559
[TBL] [Abstract][Full Text] [Related]
17. Value of symptoms to predict tilt testing outcome in patients with clinical suspicion of vasovagal syncope.
Vallejo M; Hermosillo AG; Márquez MF; Urquidez AK; Sotomayor A; Salas E; Cárdenas M
Arch Med Res; 2007 Jul; 38(5):579-83. PubMed ID: 17560466
[TBL] [Abstract][Full Text] [Related]
18. Sublingual isosorbide dinitrate-stimulated tilt test for diagnosis of vasovagal syncope in children and adolescents.
Dindar A; Cetin B; Ertuğrul T; Cantez T
Pediatr Cardiol; 2003; 24(3):270-3. PubMed ID: 12632227
[TBL] [Abstract][Full Text] [Related]
19. Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope.
Aerts A; Dendale P; Strobel G; Block P
Am Heart J; 1997 May; 133(5):504-7. PubMed ID: 9141371
[TBL] [Abstract][Full Text] [Related]
20. Neurohormonal profile before and after beta-blockade in patients with neurocardiogenic syncope.
Roul G; Riehl-Aleil V; Germain P; Bareiss P
Pacing Clin Electrophysiol; 1999 Jul; 22(7):1020-30. PubMed ID: 10456630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
